Cigna Corporation (NYSE:CI) Director William D. Zollars sold 1,232 shares of the business’s stock in a transaction that occurred on Wednesday, September 13th. The stock was sold at an average price of $187.23, for a total value of $230,667.36. The sale was disclosed in a filing with the SEC, which is available through this link.
Cigna Corporation (NYSE:CI) opened at 186.05 on Friday. Cigna Corporation has a 1-year low of $115.03 and a 1-year high of $188.36. The company has a 50-day moving average price of $179.52 and a 200 day moving average price of $165.10. The stock has a market cap of $46.84 billion, a P/E ratio of 21.47 and a beta of 0.43.
Cigna Corporation (NYSE:CI) last posted its earnings results on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, topping analysts’ consensus estimates of $2.48 by $0.43. Cigna Corporation had a net margin of 5.55% and a return on equity of 17.40%. The business had revenue of $10.32 billion during the quarter, compared to the consensus estimate of $10.26 billion. During the same quarter in the previous year, the firm posted $1.98 EPS. The firm’s revenue was up 3.6% on a year-over-year basis. Equities analysts expect that Cigna Corporation will post $10.02 earnings per share for the current fiscal year.
Large investors have recently bought and sold shares of the business. Capstone Investment Advisors Netherlands B.V. bought a new stake in Cigna Corporation in the 2nd quarter worth approximately $106,000. American Beacon Advisors Inc. bought a new stake in Cigna Corporation in the 1st quarter worth approximately $102,000. Founders Capital Management bought a new stake in Cigna Corporation in the 1st quarter worth approximately $117,000. Parallel Advisors LLC grew its position in Cigna Corporation by 62.3% in the 2nd quarter. Parallel Advisors LLC now owns 800 shares of the health services provider’s stock worth $139,000 after purchasing an additional 307 shares during the period. Finally, Mckinley Capital Management LLC Delaware bought a new stake in Cigna Corporation in the 1st quarter worth approximately $122,000. 87.96% of the stock is owned by institutional investors and hedge funds.
A number of equities analysts have recently weighed in on the company. Bank of America Corporation boosted their target price on Cigna Corporation from $193.00 to $198.00 and gave the stock a “buy” rating in a research note on Friday, June 23rd. UBS AG restated a “buy” rating and issued a $193.00 target price (up previously from $186.00) on shares of Cigna Corporation in a research note on Thursday, June 22nd. Jefferies Group LLC restated a “buy” rating and issued a $183.00 target price on shares of Cigna Corporation in a research note on Thursday, June 8th. ValuEngine upgraded Cigna Corporation from a “hold” rating to a “buy” rating in a research note on Friday, June 2nd. Finally, Royal Bank Of Canada restated a “buy” rating and issued a $177.00 target price on shares of Cigna Corporation in a research note on Tuesday, June 13th. Three analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $182.59.
About Cigna Corporation
Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.
Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with MarketBeat.com's FREE daily email newsletter.